Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Genome-Wide Association Studies Suggest Limited Immune Gene Enrichment in Schizophrenia Compared to 5 Autoimmune Diseases

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Self-Disorders in Asperger Syndrome Compared to Schizotypal Disorder: A Clinical Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Identity Disturbance, Feelings of Emptiness, and the Boundaries of the Schizophrenia Spectrum

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Perspectives on Machine Learning for Classification of Schizotypy Using fMRI Data

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Characterization of Familial and Sporadic Migraine

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genome-wide association study implicates CHRNA2 in cannabis use disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Jennie G Pouget
  • Vanessa F Gonçalves
  • Sarah L Spain
  • Hilary K Finucane
  • Soumya Raychaudhuri
  • James L Kennedy
  • Jo Knight
  • Schizophrenia Working Group of the Psychiatric Genomics Consortium
View graph of relations

There has been intense debate over the immunological basis of schizophrenia, and the potential utility of adjunct immunotherapies. The major histocompatibility complex is consistently the most powerful region of association in genome-wide association studies (GWASs) of schizophrenia and has been interpreted as strong genetic evidence supporting the immune hypothesis. However, global pathway analyses provide inconsistent evidence of immune involvement in schizophrenia, and it remains unclear whether genetic data support an immune etiology per se. Here we empirically test the hypothesis that variation in immune genes contributes to schizophrenia. We show that there is no enrichment of immune loci outside of the MHC region in the largest genetic study of schizophrenia conducted to date, in contrast to 5 diseases of known immune origin. Among 108 regions of the genome previously associated with schizophrenia, we identify 6 immune candidates (DPP4, HSPD1, EGR1, CLU, ESAM, NFATC3) encoding proteins with alternative, nonimmune roles in the brain. While our findings do not refute evidence that has accumulated in support of the immune hypothesis, they suggest that genetically mediated alterations in immune function may not play a major role in schizophrenia susceptibility. Instead, there may be a role for pleiotropic effects of a small number of immune genes that also regulate brain development and plasticity. Whether immune alterations drive schizophrenia progression is an important question to be addressed by future research, especially in light of the growing interest in applying immunotherapies in schizophrenia.

Original languageEnglish
JournalSchizophrenia Bulletin
Volume42
Issue number5
Pages (from-to)1176-84
Number of pages9
ISSN0586-7614
DOIs
Publication statusPublished - Sep 2016

    Research areas

  • Journal Article

ID: 49002441